See more : Goldenwell Biotech, Inc. (GWLL) Income Statement Analysis – Financial Results
Complete financial analysis of Precision Optics Corporation, Inc. (POCI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Precision Optics Corporation, Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
You may be interested
- Omnitek Engineering Corp. (OMTK) Income Statement Analysis – Financial Results
- Shenzhen Feima International Supply Chain Co., Ltd. (002210.SZ) Income Statement Analysis – Financial Results
- AirTrona International, Inc. (ARTR) Income Statement Analysis – Financial Results
- Round Hill Music Royalty Fund Limited (RHM.L) Income Statement Analysis – Financial Results
- Gurit Holding AG (GUR.SW) Income Statement Analysis – Financial Results
Precision Optics Corporation, Inc. (POCI)
About Precision Optics Corporation, Inc.
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 19.10M | 21.04M | 15.68M | 10.67M | 9.92M | 6.80M | 4.04M | 3.15M | 3.92M | 3.91M | 3.65M | 2.52M | 2.15M | 2.25M | 3.09M | 3.53M | 2.90M | 2.48M | 2.28M | 1.35M | 1.46M | 2.40M | 1.77M | 4.25M | 3.01M | 3.00M | 4.10M | 7.40M | 8.10M | 7.60M | 7.10M | 4.80M | 5.80M | 4.40M |
| Cost of Revenue | 13.31M | 13.31M | 10.75M | 7.24M | 6.56M | 4.68M | 2.56M | 2.38M | 2.97M | 3.11M | 2.85M | 1.87M | 1.59M | 1.49M | 1.80M | 1.93M | 2.11M | 2.00M | 2.28M | 2.00M | 2.06M | 2.07M | 3.12M | 3.44M | 1.48M | 1.80M | 3.20M | 5.20M | 5.30M | 4.80M | 5.20M | 3.20M | 4.10M | 3.40M |
| Gross Profit | 5.80M | 7.73M | 4.93M | 3.43M | 3.36M | 2.12M | 1.48M | 773.72K | 942.02K | 798.27K | 800.80K | 654.43K | 557.41K | 752.12K | 1.30M | 1.60M | 792.00K | 475.27K | 4.06K | -647.77K | -597.94K | 326.98K | -1.35M | 809.15K | 1.53M | 1.20M | 900.00K | 2.20M | 2.80M | 2.80M | 1.90M | 1.60M | 1.70M | 1.00M |
| Gross Profit Ratio | 30.35% | 36.75% | 31.43% | 32.17% | 33.89% | 31.19% | 36.70% | 24.53% | 24.05% | 20.41% | 21.93% | 25.97% | 25.90% | 33.50% | 41.92% | 45.22% | 27.29% | 19.18% | 0.18% | -47.99% | -40.82% | 13.63% | -76.03% | 19.05% | 50.68% | 40.00% | 21.95% | 29.73% | 34.57% | 36.84% | 26.76% | 33.33% | 29.31% | 22.73% |
| Research & Development | 981.78K | 992.38K | 666.48K | 624.25K | 886.13K | 505.30K | 456.38K | 464.16K | 478.27K | 492.94K | 471.11K | 630.29K | 664.70K | 825.03K | 529.41K | 737.79K | 757.85K | 1.31M | 859.94K | 1.14M | 1.32M | 1.24M | 2.27M | 3.22M | 1.69M | 900.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 7.54M | 7.38M | 5.61M | 3.71M | 3.90M | 2.10M | 1.37M | 1.31M | 1.55M | 1.55M | 1.50M | 1.26M | 1.19M | 958.51K | 1.19M | 1.45M | 1.87M | 2.10M | 1.62M | 1.86M | 1.73M | 1.88M | 2.08M | 2.10M | 1.76M | 1.60M | 2.60M | 2.30M | 2.10M | 1.90M | 1.80M | 2.90M | 1.70M | 700.00K |
| Other Expenses | 0.00 | 0.00 | 0.00 | -7.61K | 0.00 | -5.79K | -6.11K | -14.84K | 22.05K | 35.17K | 0.00 | 76.15K | 0.00 | -39.52K | -20.83K | -48.75K | -210.55K | 0.00 | -165.70K | 0.00 | 0.00 | 195.81K | 4.45M | 0.00 | 481.57K | 400.00K | 400.00K | 400.00K | 300.00K | 200.00K | 100.00K | 100.00K | 100.00K | 100.00K |
| Operating Expenses | 8.52M | 8.37M | 6.28M | 4.34M | 4.79M | 2.61M | 1.83M | 1.78M | 2.03M | 2.04M | 1.97M | 1.89M | 1.85M | 1.74M | 1.70M | 2.14M | 2.41M | 3.41M | 2.31M | 3.00M | 3.05M | 3.31M | 8.80M | 5.32M | 3.94M | 2.90M | 3.00M | 2.70M | 2.40M | 2.10M | 1.90M | 3.00M | 1.80M | 800.00K |
| Cost & Expenses | 21.83M | 21.68M | 17.03M | 11.58M | 11.35M | 7.29M | 4.39M | 4.16M | 5.00M | 5.15M | 4.82M | 3.76M | 3.45M | 3.24M | 3.50M | 4.07M | 4.52M | 5.41M | 4.59M | 5.00M | 5.11M | 5.38M | 11.92M | 8.76M | 5.42M | 4.70M | 6.20M | 7.90M | 7.70M | 6.90M | 7.10M | 6.20M | 5.90M | 4.20M |
| Interest Income | 0.00 | 218.93K | 155.66K | 5.30K | 1.00K | 1.42K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 535.00 | 207.00 | 901.00 | 5.21K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 225.11K | 218.93K | 155.66K | 5.30K | 1.00K | 1.42K | 1.86K | 3.14K | 469.00 | 0.00 | 0.00 | 1.41K | 30.21K | 60.00K | 256.73K | 453.80K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 212.38K | 210.74K | 245.24K | 146.80K | 112.22K | 38.55K | 27.22K | 33.66K | 25.86K | 21.27K | 20.02K | 20.97K | 23.37K | 57.61K | 79.04K | 62.20K | 161.17K | 120.40K | 130.11K | 241.97K | 240.85K | 265.10K | 593.49K | 730.50K | 481.57K | 400.00K | 400.00K | 400.00K | 300.00K | 200.00K | 100.00K | 100.00K | 100.00K | 100.00K |
| EBITDA | -2.51M | -427.81K | -526.57K | 50.18K | -1.31M | -573.99K | -321.40K | -968.74K | -1.01M | -1.22M | -1.15M | -1.76M | 1.02M | -934.10K | -324.20K | -475.23K | -1.46M | -2.81M | -2.14M | -3.45M | -3.41M | -2.72M | -9.55M | -3.78M | -1.93M | -1.30M | -1.70M | -100.00K | 700.00K | 900.00K | 100.00K | -1.30M | 0.00 | 300.00K |
| EBITDA Ratio | -13.15% | -2.03% | -7.41% | -7.11% | -13.21% | -6.55% | -7.96% | -30.76% | -27.12% | -32.75% | -31.60% | -48.26% | -59.05% | -41.61% | -10.48% | -13.47% | -57.60% | -113.60% | -102.57% | -245.74% | -229.08% | -105.22% | -287.79% | -88.97% | -64.10% | -43.33% | -46.34% | -1.35% | 8.64% | 10.53% | 1.41% | -29.17% | -1.72% | 6.82% |
| Operating Income | -2.72M | -638.55K | -1.35M | -905.58K | -1.42M | -484.43K | -348.62K | -1.00M | -1.06M | -1.21M | -1.16M | -1.23M | -1.28M | -991.91K | -404.14K | -542.64K | -1.62M | -2.93M | -2.31M | -3.74M | -3.70M | -2.99M | -10.14M | -4.51M | -2.41M | -1.70M | -2.10M | -500.00K | 400.00K | 700.00K | 0.00 | -1.40M | -100.00K | 200.00K |
| Operating Income Ratio | -14.26% | -3.03% | -8.62% | -8.48% | -14.34% | -7.12% | -8.63% | -31.78% | -26.95% | -31.01% | -31.76% | -48.91% | -59.69% | -44.18% | -13.06% | -15.38% | -55.90% | -118.46% | -101.02% | -276.93% | -252.65% | -124.43% | -571.77% | -106.16% | -80.10% | -56.67% | -51.22% | -6.76% | 4.94% | 9.21% | 0.00% | -29.17% | -1.72% | 4.55% |
| Total Other Income/Expenses | -225.11K | 495.87K | 424.30K | 803.66K | -1.00K | -1.42K | -1.86K | -3.14K | 21.58K | 35.17K | 0.00 | -549.76K | 2.25M | -59.79K | -255.83K | -448.59K | -48.00 | 46.01K | 36.33K | -38.94K | 18.04K | 58.55K | 172.28K | 768.54K | 255.66K | 0.00 | 200.00K | 200.00K | 0.00 | 100.00K | 0.00 | 100.00K | -100.00K | 0.00 |
| Income Before Tax | -2.95M | -142.68K | -927.46K | -101.92K | -1.42M | -613.96K | -350.48K | -1.01M | -1.03M | -1.18M | -1.16M | -1.79M | 961.88K | -1.05M | -659.97K | -991.22K | -1.62M | -2.89M | -2.27M | -3.69M | -3.68M | -2.93M | -9.97M | -3.74M | -2.15M | 0.00 | -1.90M | -300.00K | 0.00 | 800.00K | 0.00 | -1.30M | -200.00K | 0.00 |
| Income Before Tax Ratio | -15.44% | -0.68% | -5.92% | -0.95% | -14.35% | -9.02% | -8.68% | -31.88% | -26.40% | -30.11% | -31.76% | -70.91% | 44.69% | -46.84% | -21.33% | -28.09% | -55.90% | -116.61% | -99.43% | -273.18% | -251.42% | -121.99% | -562.06% | -88.07% | -71.60% | 0.00% | -46.34% | -4.05% | 0.00% | 10.53% | 0.00% | -27.08% | -3.45% | 0.00% |
| Income Tax Expense | 1.94K | 1.94K | 952.00 | 912.00 | 2.17K | 912.00 | 912.00 | 912.00 | 912.00 | 912.00 | 912.00 | 912.00 | 912.00 | 912.00 | 912.00 | 912.00 | 912.00 | 914.00 | 912.00 | 912.00 | 912.00 | 912.00 | 912.00 | 912.00 | 912.00 | 0.00 | -100.00K | 100.00K | 0.00 | 200.00K | 0.00 | -100.00K | -100.00K | 0.00 |
| Net Income | -2.95M | -144.61K | -928.42K | -102.84K | -1.43M | -614.87K | -351.39K | -1.01M | -1.03M | -1.18M | -1.16M | -1.79M | 960.97K | -1.05M | -660.88K | -992.14K | -1.62M | -2.89M | -2.27M | -3.69M | -3.68M | -2.93M | -9.97M | -3.74M | -2.16M | -1.70M | -2.00M | -400.00K | 400.00K | 600.00K | 0.00 | -1.30M | -100.00K | 200.00K |
| Net Income Ratio | -15.45% | -0.69% | -5.92% | -0.96% | -14.37% | -9.04% | -8.70% | -31.90% | -26.42% | -30.13% | -31.79% | -70.95% | 44.65% | -46.88% | -21.36% | -28.12% | -55.93% | -116.64% | -99.47% | -273.25% | -251.48% | -122.03% | -562.11% | -88.09% | -71.63% | -56.67% | -48.78% | -5.41% | 4.94% | 7.89% | 0.00% | -27.08% | -1.72% | 4.55% |
| EPS | -0.49 | -0.03 | -0.18 | -0.02 | -0.33 | -0.16 | -0.11 | -0.36 | -0.45 | -0.57 | -0.78 | -1.53 | 2.49 | -3.17 | -1.95 | -2.92 | -4.78 | -11.04 | -19.44 | -40.99 | -157.71 | -125.33 | -426.95 | -160.75 | -115.76 | -114.67 | -147.54 | -30.09 | 31.50 | 45.00 | 13.50 | -90.03 | -7.86 | 81.00 |
| EPS Diluted | -0.49 | -0.03 | -0.18 | -0.02 | -0.33 | -0.16 | -0.11 | -0.36 | -0.43 | -0.56 | -0.78 | -1.52 | 2.49 | -3.17 | -1.95 | -2.92 | -4.78 | -11.04 | -19.44 | -40.99 | -157.71 | -125.33 | -426.95 | -160.75 | -115.76 | -114.67 | -147.54 | -30.09 | 31.50 | 45.00 | 13.50 | -90.03 | -7.86 | 81.00 |
| Weighted Avg Shares Out | 6.07M | 5.67M | 5.30M | 4.43M | 4.33M | 3.83M | 3.28M | 2.78M | 2.30M | 2.07M | 1.49M | 1.17M | 387.92K | 331.59K | 339.47K | 339.47K | 339.44K | 261.67K | 116.92K | 89.99K | 23.36K | 23.36K | 23.36K | 23.28K | 18.62K | 14.83K | 13.56K | 13.29K | 13.59K | 13.33K | 11.11K | 14.44K | 12.72K | 9.52K |
| Weighted Avg Shares Out (Dil) | 6.07M | 5.67M | 5.30M | 4.43M | 4.33M | 3.83M | 3.28M | 2.78M | 2.39M | 2.09M | 1.49M | 1.17M | 425.31K | 331.59K | 339.47K | 339.47K | 339.44K | 261.67K | 116.92K | 89.99K | 23.36K | 23.36K | 23.36K | 23.28K | 18.62K | 14.83K | 13.56K | 13.29K | 13.59K | 13.33K | 11.11K | 14.44K | 12.72K | 9.52K |
Precision Optics Corporation, Inc. (POCI) Q3 2024 Earnings Call Transcript
Start Time: 17:00 January 1, 0000 5:33 PM ET Precision Optics Corporation, Inc. Q3 2024 Earnings Conference Call May 15, 2024, 17:00 PM ET Company Participants Joe Forkey - President and CEO Wayne Coll - CFO Robert Blum - Lytham...
Precision Optics Reports Third Quarter Fiscal Year 2024 Financial Results
GARDNER, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, announced operating results on an unaudited basis for its third quarter...
Precision Optics Announces Record $9 Million Production Order for High Volume Single-Use Cystoscopy Surgery Program
GARDNER, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced a $9 million production order from a leading surgical...
Precision Optics Corporation Schedules Third Quarter of Fiscal Year 2024 Conference Call for Wednesday, May 15, 2024
GARDNER, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced that it has scheduled a conference call...
Precision Optics Announces Receipt of $1.26 Million Follow On Production Order from Large Defense Company
GARDNER, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced the receipt of a follow-on production order totaling approximately...
Precision Optics to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024
GARDNER, Mass., April 23, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced that Dr. Joe Forkey, Chief Executive Officer, and Wayne...
Precision Optics Announces Receipt of $720,000 Follow-On Production Order from Top Tier Defense/Aerospace Customer for New Optical Application
GARDNER, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced it has received a $720,000 follow on production order...
Precision Optics Corporation, Inc. (POCI) Q2 2024 Earnings Call Transcript
Precision Optics Corporation, Inc. (POCI) Q2 2024 Earnings Call Transcript
Precision Optics Reports Second Quarter Fiscal Year 2024 Financial Results
Conference Call Scheduled for today, February 14, 2024, at 5:00pm ET. GARDNER, Mass.
Precision Optics Corporation Schedules Second Quarter of Fiscal Year 2024 Conference Call for Wednesday, February 14, 2024
GARDNER, Mass. , Feb. 8, 2024 /PRNewswire/ -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced that it has scheduled a conference call...
Source: https://incomestatements.info
Category: Stock Reports